论文部分内容阅读
Changes of serum Th1/Th2 cytokines level in pregnant women with HBV infection after telbivudine trea
【机 构】
：
Institute of Infectious Disease,Southwest Hospital,Third Military Medical University,Chongqing,China
【出 处】
：
第二届全国病毒感染与器官功能衰竭学术会议
【发表日期】
：
2013年8期
其他文献
Immunodominant CD4+ T-cell responses to Influenza A virus in healthy individuals focus on Matrix 1 a
会议
Torque teno virus (TTV) has been found world-wide prevalent in healthy population and patients with various diseases, but its ethological role had not been determined yet. Using high throughput unbias
目的:探讨慢性乙型肝炎(HBV)感染者血清中肝特异性自身抗体的检出率及临床意义.方法:采用间接免疫荧光法,对186例HBV患者血清进行肝特异性自身抗体检测,回顾性分析AST、ALT、ALP和GGT等肝功能生化指标与自身抗体检出阳性率的相关性.结果:186例HBV感染者检出自身抗体阳性66例,阳性率率35.5％;HBV携带组、慢性肝炎组与肝硬化组肝特异性抗核抗体(ANA)检出率分别为25.0％,24
Dermatomyositis associated with hepatitis B virus-related hepatocellular carcinoma:HBV-related extra
会议
Serum Testosterone Levels And Androgen Receptor CAG Polymorphism Correlate With Hepatitis B Virus (H
Background: Augmentation of androgen/androgen receptor (AR) pathway may influence chronic hepatitis B (CHB) more likely in males.AR activity is modulated by a polymorphic CAG repeat sequence in AR exo
Backgrounds and Objectives Accurate prediction of the sustained virological response (SVR) of antiviral therapy against chronic hepatitis B (CHB) is still a key problem needing profound investigation.
会议
Effect of HLA-DP and IL28B gene polymorphisms on response to interferon treatment in HBeAg seroposit
Aim The reason why the majority of chronic hepatitis B (CHB) patients do not respond to conventional interferon α (IFNα) or pegylated interferon (Peg-IFN) treatment has not been formally demonstrated.
Polymorphisms of TLR-IFN pathway genes and the risk for persistently chronic hepatitis B virus infec
会议
BTLA up-regulation associated with impaired cytotoxic CD8+ T-cell function and disease progression o
B- and T-lymphocyte attenuator (BTLA) negatively regulates immune responses; however,it remains unknown the expression profile and functional role of BTLA in patients with hepatocellular carcinoma (HC